Looking for clinical-relevant biospecimen in T1D?
CBmed is scaling patient-derived disease models & biomarker research in precision diabetes
What We Deliver
CBmed is building a comprehensive translational type-1-diabetes (T1D) research program centered around patient-derived disease models at a population level.
By integrating patient cohorts, stem cell technologies, immune profiling, high content phenomics, AI, biomarker discovery, into a digital framework, we enable partners to investigate disease mechanisms, stratify patients, identify responders, and accelerate therapeutic development.
Partner with us to build a unique personalized end-to-end disease modeling platform to tackle the burden that is T1D!
Strategic Offer
Our flexible, partnership-driven approach allows us to tailor every aspect of the collaboration, ensuring that the generated clinical, immunological, and translational data directly address your strategic objectives.
To provide an efficient entry point for a strategic alliance, we offer access to the prospective T-Islet cohort that allows you to de-risk your target early in preclinical & clinical trials in T1D.
As a first step towards a long-term strategic partnership, we offer an initial test phase that will include:
- Access to 5 patient-derived blood samples (T-Islet) including clinical metadata
- Immuno-profiling of autoreactive immune cells or autoantibodies in relation to clinical disease phenotypes
- Deliver first insights into biomarker translation strategies
- Define a roadmap how to access patient-derived stem cell islets at scale for personalized disease modelling